Alejandro Hernandez

Alejandro Hernandez

Auto-generated profile, based on publicly available information

Alejandro Hernandez

ICES , Toronto, Ontario

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
NNNahid Norouzi-Gheidari
Nahid Norouzi-Gheidari
AHAlejandro Hernandez
Alejandro Hernandez
PAPhilippe Archambault
Philippe Archambault
JHJohanne Higgins
Johanne Higgins
LPLise Poissant
Lise Poissant
Dahlia KairyDahlia Kairy
Dahlia Kairy
(1) Background: Increasing the amount of therapy time has been shown to improve motor function in stroke survivors. However, it is often not possible to increase the amount of therapy time provided in the current one-on-one therapy models. Rehabilitation-based virtual reality exergame systems, such as Jintronix, can be offered to stroke survivors as an adjunct to traditional therapy. The goal of this study was to examine the safety and feasibility of providing additional therapy using an exergame system and assess its preliminary clinical efficacy. (2) Methods: Stroke survivors receiving outpatient rehabilitation services participated in this pilot randomized control trial in which the intervention group received 4 weeks of exergaming sessions in addition to traditional therapy sessions. (3) Results: Nine subjects in the intervention and nine subjects in the control group completed the study. The intervention group had at least two extra sessions per week, with an average duration of 44 min per session and no serious adverse events (falls, dizziness, or pain). The efficacy measures showed statistically meaningful improvements in the activities of daily living measures (i.e., MAL-QOM (motor activity log-quality of movement) and both mobility and physical domains of the SIS (stroke impact scale) with mean difference of 1.0%, 5.5%, and 6.7% between the intervention and control group, respectively) at post-intervention. (4) Conclusion: Using virtual reality exergaming technology as an adjunct to traditional therapy is feasible and safe in post-stroke rehabilitation and may be beneficial to upper extremity functional recovery.

27 September 2022 in JMIR Serious Games
Verified
Journal Article
Open access
AHAlejandro Hernandez
Alejandro Hernandez
LBLiudmila Bubyr
Liudmila Bubyr
PAPhilippe Archambault
Philippe Archambault
JHJohanne Higgins
Johanne Higgins
MLMindy F. Levin
Mindy F. Levin
Dahlia KairyDahlia Kairy
Dahlia Kairy
Background: A growing number of stroke survivors are left with little to no rehabilitation services upon discharge from stroke rehabilitation, although arm deficits may persist or develop from disuse once rehabilitation services have ceased. Virtual reality (VR)–based rehabilitation, combined with new technologies such as telerehabilitation, including serious games using VR environments that encourage users to practice functional movements from home with minimal supervision, may have an important role to play in optimizing and maintaining upper extremity (UE) function. Objective: The primary objective of this study is to determine the extent to which a 1-month intervention using a VR-based serious game is effective in improving UE function compared with an evidence-based home exercise program. A secondary objective is to assess the feasibility of implementing the intervention for chronic stroke rehabilitation in participants’ homes. Methods: A total of 51 chronic stroke participants were randomized to treatment (n=26, 51%; Jintronix system) or standard care (n=25, 49%; standardized Graded Repetitive Arm Supplementary Program kit home program) groups. The participants were evaluated at baseline (before), immediately after the intervention (after), and at follow-up (4 weeks). The primary outcome measure was the Fugl-Meyer Assessment for UE (FMA-UE). Secondary outcome measures included the Stroke Impact Scale and an abridged version of the Motor Activity Log-14. Self-reported number of sessions was logged for the standard care group. Results: No statistically significant differences between groups were found across measures. Overall time effects were found for the FMA-UE (P=.045), specifically between preintervention and postintervention time points for both groups (P=.03). A total of 9 participants in the treatment group reached or surpassed the minimal clinically important difference in scores for the FMA-UE, with 7 (78%) of them having baseline low or moderate arm function, compared with 3 (33%) participants in the standard care group. Furthermore, 56% (9/16) of the participants in the treatment group who actively engaged with the system reached the minimal clinically important difference for the FMA-UE, compared with none for the 0% (0/10) less-active participants. Conclusions: These findings suggest that UE training for chronic stroke survivors using virtual rehabilitation in their home may be as effective as a gold standard home exercise program and that those who used the system the most achieved the greatest improvement in UE function, indicating its relevance to being included as part of ongoing rehabilitation services. Trial Registration: ClinicalTrials.gov NCT02491203; https://clinicaltrials.gov/ct2/show/NCT02491203 International Registered Report Identifier (IRRID): RR2-10.1016/j.cct.2015.12.006

14 March 2026 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
KBKevin A Brown
Kevin A Brown
BCBryan Coburn
Bryan Coburn
AHAlejandro Hernandez
Alejandro Hernandez
BLBradley J Langford
Bradley J Langford
VLValerie Leung
Valerie Leung
NDNick Daneman
Nick Daneman
Clostridioides difficile infection (CDI) is principally precipitated by antibiotics, due to their disruption of gut commensal bacteria. The comparative role of nonantibiotic drugs is poorly characterized. We examined the contribution of antibiotic and nonantibiotic drugs to CDI risk among residents age >65 years old and not hospitalized in the prior 30 days, between 2018 and 2023. The study used a case-cohort study design, with logistic regression analysis. The case definition consisted of first incident CDI, identified using comprehensive C. difficile testing, hospitalization, and treatment data. Outpatient oral drug exposures were measured in a 1–90-day window prior to case and control days. Adjusted regression models included covariates for age, sex, year and quarter, region, comorbid conditions, healthcare exposures, and drug exposures. Among 16 196 CDI case patients and 549 831 controls, 335 drugs were included. After adjustment, the antibiotics amoxicillin-clavulanate (odds ratio [OR], 6.05 [95% confidence interval (CI), 5.69–6.43]), clindamycin (16.83 [15.53–18.24]), ciprofloxacin (3.83 [3.59–4.09]), and cephalexin (3.05 [2.86–3.25]), were the largest contributors to CDI risk. Nonantibiotic drugs pantoprazole (OR, 1.33 [95% CI, 1.27–1.39]) and ferrous fumarate (1.71 [1.61–1.82]) were the next largest. Metformin had a protective association (OR, 0.67 [95% CI, .63–.72]). In a meta-regression on a subset of 182 drugs, in vitro anticommensal activity was positively associated with CDI risk (P < .001). This study provides insights into CDI etiology and avenues for stewardship and drug repurposing to combat CDI and antimicrobial resistance.

24 February 2022 in JMIR Preprints
Verified
Preprint
Open access
AHAlejandro Hernandez
Alejandro Hernandez
LBLiudmila Bubyr
Liudmila Bubyr
PAPhilippe Archambault
Philippe Archambault
JHJohanne Higgins
Johanne Higgins
MLMindy F. Levin
Mindy F. Levin
Dahlia KairyDahlia Kairy
Dahlia Kairy
BACKGROUND A growing number of stroke survivors are left with little to no rehabilitation services upon discharge from stroke rehabilitation, although arm deficits may persist or develop from disuse once rehabilitation services have ceased. Virtual reality-based rehabilitation, combined with new technologies such as telerehabilitation, including serious games using virtual reality environments that encourage users to practice functional movements from home with minimal supervision, may have an important role to play in optimizing and maintaining upper-extremity (UE) function. OBJECTIVE The primary objective was to determine the extent to which a one-month intervention using a virtual reality-based serious game is effective in improving upper extremity function compared to an evidence-based home exercise program. A secondary objective was to assess the feasibility of implementing the intervention for chronic stroke rehabilitation in participants’ homes. METHODS Fifty-one chronic stroke participants were randomized to Treatment (n=26; Jintronix system) or Standard care (n=25; standardized GRASP kit home program) groups. Participants were evaluated at baseline (pre), immediately after the intervention (post) and at follow-up (4 weeks). The primary outcome measure was the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE). Secondary outcome measures included the Stroke Impact Scale (SIS) and an abridged version of the Motor Activity Log (MAL-14). RESULTS No statistically significant differences between groups were found across measures. Overall time effects were found for the FMA-UE (P=.045), specifically between pre-intervention and post-intervention time points for both groups (P=.03). Nine participants in the treatment group reached or surpassed minimally clinically important difference (MCID) in scores for the FMA-UE, 7 of them having baseline low or moderate arm function, as compared to 3 participants for the standard care group. Nine of the 16 participants in the treatment group who used the system for a total of at least 400 minutes in the program reached MCID for the FMA-UE, as compared to none of the 10 participants who used it less than 400 minutes. CONCLUSIONS These findings suggest that UE training for chronic stroke survivors using virtual rehabilitation in their home may be as effective as a gold-standard home exercise program, and that those who on average used the system more than 20 minutes a day 5 times a week achieved greater improvement in UE function, indicating its relevance to be included as part of ongoing rehabilitation services. CLINICALTRIAL NCT02491203 (www.clinicaltrials.gov) INTERNATIONAL REGISTERED REPORT RR2-10.1016/j.cct.2015.12.006

19 October 2026 in Clinical Infectious Diseases
Verified
Journal Article
Open access
KHKantaphong Hakin
Kantaphong Hakin
NDNick Daneman
Nick Daneman
AHAlejandro Hernandez
Alejandro Hernandez
BLBradley J Langford
Bradley J Langford
VLValerie Leung
Valerie Leung
KBKevin A Brown
Kevin A Brown
Background: Despite reductions in hospital-associated Clostridioides difficile infection (CDI) incidence in Canada and the United States, the incidence of community-associated CDI (CA-CDI) has remained high. We sought to investigate whether neighbourhood-level variation in antibiotic utilization is associated with CA-CDI. Method: We conducted a neighbourhood-level ecological study across 1,520 neighbourhoods in Ontario, Canada. Residents aged ≥66 without hospitalization in the prior 30 days were eligible for inclusion from 2017 to 2023. Antibiotic utilization, CDI cases, and population were identified for each neighbourhood using comprehensive province-wide databases. CA-CDI rate was the outcome (incident cases of CA-CDI/10,000 person-years). Rate of antibiotic utilization (DOT per 1000 person-days) was the primary exposure. The rate-ratio (RR) of CA-CDI associated with increased antibiotic utilization was estimated using negative-binomial regression, adjusting for 8 demographic and health care covariates. We also evaluated risk based on low-, moderate-, and high-risk antibiotic strata based on published literature. Result: We identified 19,757 CA-CDI cases. We observed substantial variation in antibiotic utilization across neighbourhoods (Median=21.1 DOT/1000 person-days; interquartile range [IQR], 16.7–25.6). After adjustments, we observed an association between overall antibiotic utilization (RR=1.13 per 10-point increase in DOT; 95% confidence interval [95%CI], 1.09–1.18). A gradient wherein higher risk antibiotic agents were more strongly associated with CA-CDI was apparent (Low-risk: RR=1.08; 95%CI, 1.01–1.15; Moderate-risk: RR=1.27; 95%CI, 1.15–1.39; High-risk: RR=1.73; 95%CI, 1.13–2.66). Discussion: Neighbourhoods with higher antibiotic utilization, especially for moderate and high-risk antibiotics, have higher CA-CDI incidence. Reducing variability in neighbourhood antibiotic utilization could help reduce the burden of CDI.